Intravitreal Aflibercept Injection as a Surgical Adjuvant in Severe Proliferative Diabetic Retinopathy
Phase of Trial: Phase II
Latest Information Update: 19 Jan 2017
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic retinopathy
- Focus Adverse reactions
- 13 Jan 2017 Status changed from active, no longer recruiting to completed.
- 19 Dec 2013 Planned End Date changed from 1 Sep 2013 to 1 Apr 2014 as reported by ClinicalTrials.gov.
- 19 Dec 2013 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.